These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 8822340
21. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone. Liu CC, Kalu DN, Salerno E, Echon R, Hollis BW, Ray M. J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755 [Abstract] [Full Text] [Related]
22. The addition of a raloxifene analog (LY117018) allows for reduced PTH(1-34) dosing during reversal of osteopenia in ovariectomized rats. Hodsman AB, Drost D, Fraher LJ, Holdsworth D, Thornton M, Hock J, Bryant H, Watson PH. J Bone Miner Res; 1999 May; 14(5):675-9. PubMed ID: 10320515 [Abstract] [Full Text] [Related]
23. An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats. Armamento-Villareal R, Ziambaras K, Abbasi-Jarhomi SH, Dimarogonas A, Halstead L, Fausto A, Avioli LV, Civitelli R. J Bone Miner Res; 1997 Mar; 12(3):384-92. PubMed ID: 9076581 [Abstract] [Full Text] [Related]
24. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats. Verhaeghe J, van Bree R, Van Herck E, Thomas H, Skottner A, Dequeker J, Mosekilde L, Einhorn TA, Bouillon R. J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780 [Abstract] [Full Text] [Related]
25. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. Rixon RH, Whitfield JF, Gagnon L, Isaacs RJ, Maclean S, Chakravarthy B, Durkin JP, Neugebauer W, Ross V, Sung W. J Bone Miner Res; 1994 Aug; 9(8):1179-89. PubMed ID: 7976500 [Abstract] [Full Text] [Related]
26. Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats. Shirota T, Tashiro M, Ohno K, Yamaguchi A. J Oral Maxillofac Surg; 2003 Apr; 61(4):471-80. PubMed ID: 12684966 [Abstract] [Full Text] [Related]
27. Evaluation of long-term sequential changes in bone mass and strength following withdrawal of incadronate disodium (YM175) in ovariectomized rats. Miyakoshi N, Sato K, Tamura Y, Tsuchida T, Kudo T, Kasukawa Y. J Orthop Sci; 2001 Apr; 6(2):167-76. PubMed ID: 11484104 [Abstract] [Full Text] [Related]
28. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY. Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596 [Abstract] [Full Text] [Related]
29. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH. Iwaniec UT, Samnegård E, Cullen DM, Kimmel DB. Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618 [Abstract] [Full Text] [Related]
30. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats. Washimi Y, Ito M, Morishima Y, Taguma K, Ojima Y, Uzawa T, Hori M. Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708 [Abstract] [Full Text] [Related]
31. Maintenance of bone mass by physical exercise after discontinuation of intermittent hPTH(1-34) administration. Yamamoto N, Takahashi HE, Tanizawa T, Fujimoto R, Hara T, Tanaka S. Bone Miner; 1993 Dec; 23(3):333-42. PubMed ID: 8148673 [Abstract] [Full Text] [Related]
32. Pharmacological treatment of osteopenia induced by gastrectomy or ovariectomy in young female rats. Andersson N, Surve VV, Lehto-Axtelius D, Andersson K, Ryberg B, Ohlsson C, Håkanson R. Acta Orthop Scand; 2004 Apr; 75(2):201-9. PubMed ID: 15180236 [Abstract] [Full Text] [Related]
33. Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R, Hock JM. J Bone Miner Res; 2001 Jan; 16(1):157-65. PubMed ID: 11149480 [Abstract] [Full Text] [Related]
34. A histomorphometric study on effects of single and concurrent intermittent administration of human PTH (1-34) and bisphosphonate cimadronate on tibial metaphysis in ovariectomized rats. Mashiba T, Tanizawa T, Takano Y, Takahashi HE, Mori S, Norimatsu H. Bone; 1995 Oct; 17(4 Suppl):273S-278S. PubMed ID: 8579928 [Abstract] [Full Text] [Related]
35. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats. Qi H, Li M, Wronski TJ. J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319 [Abstract] [Full Text] [Related]
36. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats. Kimmel DB, Bozzato RP, Kronis KA, Coble T, Sindrey D, Kwong P, Recker RR. Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456 [Abstract] [Full Text] [Related]
37. Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats. Jee WS, Lin BY, Ma YF, Ke HZ. J Bone Miner Res; 1995 Jun; 10(6):963-70. PubMed ID: 7572321 [Abstract] [Full Text] [Related]
39. Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Komrakova M, Stuermer EK, Werner C, Wicke M, Kolios L, Sehmisch S, Tezval M, Daub F, Martens T, Witzenhausen P, Dullin C, Stuermer KM. Bone; 2010 Sep; 47(3):480-92. PubMed ID: 20580683 [Abstract] [Full Text] [Related]
40. The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats. Andreassen TT, Oxlund H. J Bone Miner Res; 2000 Nov; 15(11):2266-75. PubMed ID: 11092409 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]